Regarding deteriorations in blood glucose levels among COVID-19 patients with previous T2DM, a recent study (151) reported that mRNA and protein expression levels of ACE2 in human islet β cells were significantly elevated under the actions of inflammatory cytokines, which may make β cells to be more vulnerable to severe infections. Here, ACE2 is linked to COVID-19.